309 related articles for article (PubMed ID: 26774019)
41. Effect of postprandial hyperglycaemia on blood viscosity in aged patients suffering from type 2 diabetes as compared with healthy volunteers.
Coppola L; Cerciello T; Boviatsi P; Pastore A; Coppola A; Antonio G; Mastrolorenzo L; Marfella R; Gombos G
Blood Coagul Fibrinolysis; 2007 Dec; 18(8):745-50. PubMed ID: 17982315
[TBL] [Abstract][Full Text] [Related]
42. Glucose metabolism and hyperglycemia.
Giugliano D; Ceriello A; Esposito K
Am J Clin Nutr; 2008 Jan; 87(1):217S-222S. PubMed ID: 18175761
[TBL] [Abstract][Full Text] [Related]
43. Effect of postprandial hyperglycemia at clinic visits on the incidence of retinopathy in patients with type 2 diabetes: An analysis using real-world long-term follow-up data.
Takao T; Takahashi K; Yoshida Y; Kushiyama A; Onishi Y; Tahara T; Shimmei A; Kikuchi T; Suka M; Yanagisawa H; Iwamoto Y; Kasuga M
J Diabetes Investig; 2020 Jul; 11(4):930-937. PubMed ID: 31811705
[TBL] [Abstract][Full Text] [Related]
44. Impact of improving postprandial glycemic control with intensifying insulin therapy in type 2 diabetes.
Yacoub T
Postgrad Med; 2017 Nov; 129(8):791-800. PubMed ID: 29032696
[TBL] [Abstract][Full Text] [Related]
45. Daily inhibition of postprandial hyperglycaemia with JTT-608, a novel oral antidiabetic agent, ameliorates pancreatic function in neonatally streptozotocin-treated rats.
Ohta T; Sasase T; Miyajima K; Matsui K; Matsushita M; Furukawa N; Yonemori F
Diabetes Obes Metab; 2005 Sep; 7(5):517-24. PubMed ID: 16050944
[TBL] [Abstract][Full Text] [Related]
46. The association of long-term glycaemic variability versus sustained chronic hyperglycaemia with heart rate-corrected QT interval in patients with type 2 diabetes.
Su JB; Yang XH; Zhang XL; Cai HL; Huang HY; Zhao LH; Xu F; Chen T; Cheng XB; Wang XQ; Lu Y
PLoS One; 2017; 12(8):e0183055. PubMed ID: 28846720
[TBL] [Abstract][Full Text] [Related]
47. Relative contributions of preprandial and postprandial glucose exposures, glycemic variability, and non-glycemic factors to HbA
Færch K; Alssema M; Mela DJ; Borg R; Vistisen D
Nutr Diabetes; 2018 Jun; 8(1):38. PubMed ID: 29855488
[TBL] [Abstract][Full Text] [Related]
48. Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes.
Colette C; Monnier L
Horm Metab Res; 2007 Sep; 39(9):683-6. PubMed ID: 17846977
[TBL] [Abstract][Full Text] [Related]
49. Role of postprandial hyperglycaemia in cardiovascular disease in diabetes.
Yamagishi SI; Nakamura K; Matsui T; Ueda SI; Imaizumi T
Int J Clin Pract; 2007 Jan; 61(1):83-7. PubMed ID: 17229182
[TBL] [Abstract][Full Text] [Related]
50. Correlation of Fasting Versus Postprandial Plasma Glucose with HbA1c in Chinese Type 2 Diabetic Patients Taking Different Hypoglycemic Agents.
Wang X; Wang F; Wang H; Li N
Clin Lab; 2017 Jul; 63(7):1293-1300. PubMed ID: 28792708
[TBL] [Abstract][Full Text] [Related]
51. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels.
Woerle HJ; Neumann C; Zschau S; Tenner S; Irsigler A; Schirra J; Gerich JE; Göke B
Diabetes Res Clin Pract; 2007 Aug; 77(2):280-5. PubMed ID: 17240473
[TBL] [Abstract][Full Text] [Related]
52. Guideline for management of postmeal glucose.
Ceriello A; Colagiuri S; Gerich J; Tuomilehto J;
Nutr Metab Cardiovasc Dis; 2008 May; 18(4):S17-33. PubMed ID: 18501571
[TBL] [Abstract][Full Text] [Related]
53. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
54. Starting bedtime glargine versus NPH insulin in poorly controlled type 2 diabetic patients with various hyperglycemia types (fasting type or postprandial type).
Vähätalo MA; Viikari J; Rönnemaa T
Acta Diabetol; 2014 Apr; 51(2):233-8. PubMed ID: 23880900
[TBL] [Abstract][Full Text] [Related]
55. Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update.
Ceriello A; Davidson J; Hanefeld M; Leiter L; Monnier L; Owens D; Tajima N; Tuomilehto J;
Nutr Metab Cardiovasc Dis; 2006 Oct; 16(7):453-6. PubMed ID: 16934443
[TBL] [Abstract][Full Text] [Related]
56. Nateglinide provides tighter glycaemic control than glyburide in patients with Type 2 diabetes with prevalent postprandial hyperglycaemia.
Bellomo Damato A; Stefanelli G; Laviola L; Giorgino R; Giorgino F
Diabet Med; 2011 May; 28(5):560-6. PubMed ID: 21204958
[TBL] [Abstract][Full Text] [Related]
57. Breakfast replacement with a low-glycaemic response liquid formula in patients with type 2 diabetes: a randomised clinical trial.
Stenvers DJ; Schouten LJ; Jurgens J; Endert E; Kalsbeek A; Fliers E; Bisschop PH
Br J Nutr; 2014 Aug; 112(4):504-12. PubMed ID: 25091284
[TBL] [Abstract][Full Text] [Related]
58. Postprandial glucose regulation and diabetic complications.
Ceriello A; Hanefeld M; Leiter L; Monnier L; Moses A; Owens D; Tajima N; Tuomilehto J
Arch Intern Med; 2004 Oct; 164(19):2090-5. PubMed ID: 15505121
[TBL] [Abstract][Full Text] [Related]
59. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).
Monnier L; Lapinski H; Colette C
Diabetes Care; 2003 Mar; 26(3):881-5. PubMed ID: 12610053
[TBL] [Abstract][Full Text] [Related]
60. Correlations of fasting and postprandial blood glucose increments to the overall diurnal hyperglycemic status in type 2 diabetic patients: variations with levels of HbA1c.
Kikuchi K; Nezu U; Shirakawa J; Sato K; Togashi Y; Kikuchi T; Aoki K; Ito Y; Kimura M; Terauchi Y
Endocr J; 2010; 57(3):259-66. PubMed ID: 20086313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
